Access to life-saving medicines in Europe

This procedure focuses on improving the availability and affordability of essential medicines across the European Union. It aims to address gaps in healthcare access to ensure that patients can receive critical treatments regardless of their location or economic status.

This will primarily affect patients with rare or severe diseases, healthcare providers, and pharmaceutical companies by potentially altering how medicines are distributed and priced.